Servier Pharmaceuticals ISS - Clinical Integration of Therapeutic Innovations in IDH-Mutant Glioma Pathways to Improved Patient Outcomes

session DESCRIPTION

CME Credits: MedscapeLIVE designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Target Audience: This educational activity is intended for an audience of radiation oncologists, medical oncologists, neuro-oncologists, neurosurgeons, radiologists and the rest of the oncology care team.